Moleculin Reports Cardiac Safety Data for Annamycin
HOUSTON — September 28, 2026 Moleculin Biotech, Inc. announced publication of a peer-reviewed pooled analysis of the cardiac safety...
AML
Advertisement
ViferaXS Raises €12M to Advance CLL Phase II Trial
TÜBINGEN, Germany — September 23, 2026 ViferaXS GmbH announced the close of a Series A financing round of up...
PureTech Gains FDA Fast Track for LYT-200 in HR-MDS
LONDON — September 21, 2026 PureTech Health announced the successful completion of an End-of-Phase 1 meeting with the U.S....
LEO Pharma Acquires Dersimelagon for Rare Skin Diseases
BALLERUP, DENMARK, August 18, 2026 LEO Pharma has entered into an agreement to acquire worldwide rights to dersimelagon from...
Smith+Nephew and Imperial Advance Surgical Robotics
LONDON, August 18, 2026 Smith+Nephew and Imperial College London have launched a new five-year partnership to accelerate innovation in...
Advertisements
InnoCare Advances Phase III AML Trial of Mesutoclax
BEIJING, August 18, 2026 InnoCare Pharma announced that China’s Center for Drug Evaluation (CDE) of the National Medical Products...
BrainStorm Advances NurOwn ALS Program Toward Phase 3b
New York, United States, August 14, 2026 BrainStorm Cell Therapeutics Inc. announced its financial results for the second quarter...
Kyowa Kirin Advances AI-Powered Drug Discovery R&D
Tokyo, Japan, August 16, 2026 Kyowa Kirin Co., Ltd. has selected Cognizant and Benchling as partners to implement an...
Actinium Advances Actimab-A With Manufacturing Expansion
New York, United States, August 14, 2026 Actinium Pharmaceuticals, Inc. announced new intellectual property and manufacturing developments supporting its...
Kura Oncology Publishes Ziftomenib Data in Blood
SAN DIEGO, August 10, 2026 Kura Oncology, Inc. announced the publication of new research in Blood detailing the discovery...
Advertisement
